Your browser doesn't support javascript.
loading
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India.
Kazemian, Pooyan; Ding, Delaney D; Scott, Justine A; Feser, Mary K; Biello, Katie; Thomas, Beena E; Dange, Alpana; Bedoya, C Andres; Balu, Vinoth; Rawat, Shruta; Kumarasamy, Nagalingeswaran; Mimiaga, Matthew J; O'Cleirigh, Conall; Weinstein, Milton C; Kumar, Jacob Prem; Kumar, Senthil; Mayer, Kenneth H; Safren, Steven A; Freedberg, Kenneth A.
Afiliación
  • Kazemian P; Department of Operations, Weatherhead School of Management, Case Western Reserve University, Cleveland, Ohio.
  • Ding DD; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Scott JA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Feser MK; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Biello K; Center for Health Promotion and Health Equity.
  • Thomas BE; Department of Behavioral and Social Sciences.
  • Dange A; Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
  • Bedoya CA; The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.
  • Balu V; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, Tamil Nadu.
  • Rawat S; The Humsafar Trust, Mumbai, Maharashtra, India.
  • Kumarasamy N; Behavioral Medicine Program, Massachusetts General Hospital.
  • Mimiaga MJ; Harvard Medical School, Boston, Massachusetts, USA.
  • O'Cleirigh C; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, Tamil Nadu.
  • Weinstein MC; The Humsafar Trust, Mumbai, Maharashtra, India.
  • Kumar JP; CART Clinical Research Site, Infectious Diseases Medical Centre, Voluntary Health Services, Chennai, Tamil Nadu, India.
  • Kumar S; The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.
  • Mayer KH; Department of Epidemiology, UCLA Fielding School of Public Health.
  • Safren SA; Department of Psychiatry and Biobehavioral Sciences, UCLA Geffen School of Medicine.
  • Freedberg KA; UCLA Center for LGBTQ+ Advocacy, Research & Health, Los Angeles, California.
AIDS ; 36(9): 1223-1232, 2022 07 15.
Article en En | MEDLINE | ID: mdl-35471644
ABSTRACT

OBJECTIVE:

MSM in India are at a high risk for HIV infection given psychosocial challenges, sexual orientation stress, and stigma. We examined the cost-effectiveness of a novel resilience-based psychosocial intervention for MSM in India.

DESIGN:

We parameterized a validated microsimulation model (CEPAC) with India-specific data and results from a randomized trial and examined two strategies for MSM status quo HIV care ( SQ ), and a trial-based psychosocial intervention ( INT ) focused on building resilience to stress, improving mental health, and reducing condomless anal sex (CAS).

METHODS:

We projected lifetime clinical and economic outcomes for MSM without HIV initially. Intervention effectiveness, defined as reduction in self-reported CAS, was estimated at 38%; cost was $49.37/participant. We used a willingness-to-pay threshold of US$2100 (2019 Indian per capita GDP) per year of life saved (YLS) to define cost-effectiveness. We also assessed the 5-year budget impact of offering this intervention to 20% of Indian MSM.

RESULTS:

Model projections showed the intervention would avert 2940 HIV infections among MSM over 10 years. Over a lifetime horizon, the intervention was cost-effective (ICER = $900/YLS). Results were most sensitive to intervention effectiveness and cost; the intervention remained cost-effective under plausible ranges of these parameters. Offering this intervention in the public sector would require an additional US$28 M over 5 years compared with SQ .

CONCLUSION:

A resilience-based psychosocial intervention integrated with HIV risk reduction counseling among MSM in India would reduce HIV infections and be cost-effective. Programs using this approach should be expanded as a part of comprehensive HIV prevention in India.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_financiamento_saude / 2_enfermedades_transmissibles Asunto principal: Infecciones por VIH / Minorías Sexuales y de Género Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_financiamento_saude / 2_enfermedades_transmissibles Asunto principal: Infecciones por VIH / Minorías Sexuales y de Género Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article
...